Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Nirogacestat in Patients With Kaposi Sarcoma

NCT07539454 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT07539454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07539454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Nirogacestat in Patients With Kaposi Sarcoma
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 17, 2026
Completion date
February 17, 2030
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids-related kaposi sarcoma, skin kaposi sarcoma